CYP7A1;Cholesterol 7-alpha-monooxygenase;cytochrome P450 family 7 subfamily A member 1;CYP7A1;CYP7;cytochrome P450, subfamily VIIA (cholesterol 7 alpha-monooxygenase), polypeptide 1;cytochrome P450, family 7, subfamily A, polypeptide 1
RBM6;RNA binding motif protein 6;RBM6;DEF-3;3G2;NY-LU-12;g16;DEF3
NID1;nidogen 1;NID1;NID;nidogen (enactin);entactin
QDPR;quinoid dihydropteridine reductase;QDPR;DHPR;PKU2;SDR33C1
FAM159A;family with sequence similarity 159 member A;FAM159A;family with sequence similarity 159, member A;MGC52498
polycyclic aromatic hydrocarbon
naphthoflavone
indigoid
tryptophan metabolite
Phenobarbital
CITCO
carbaldehyde
clotrimazole
TCPOBOP
dichloropyridyloxy
phenytoin
Bile acid
Lithocholic acid
chenodeoxycholic acid
GW4064
Glucocorticoid
oxysterol
GW3965
T0901317
paxilline
F(3)methylAA
acetyl-podocarpic dimmer
oltipraz
phenolic antioxidant
fibrate
WY-14
WY-643
dehydroepiandrosterone
fatty acid
rifampin
rifabutin
hyperforin
paclitaxel
nifedine
adalat
clotrimazole
ritonavir 
amprenavir
nelfinavir
bosentan
phenytoin
efavirenz
lovastatin 
simvastatin
troglitazone
vitamin E
vitamin K2
avasimibe 
carbamazepine
spironolactone
spiro
sulphinpyrazone 
topotecan
etoposide
Polychlorinated biphenyl
phthalate momoester
omeprazole
troleandomycin
mifepristone 
cyproterone acetate
guggulsterone
RU486
progesterone analog
vd3
EB1089
KH1060
RO 25-9022
vitamin D analog
retinoic acid
9-cis-retinoic acid
dimethoxyflavone
androstane
AGN34
CIS-
high-density lipoprotein
low-density lipoprotein
ET743
AKR1C4;aldo-keto reductase family 1 member C4;AKR1C4;CHDR;aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4);DD4;HAKRA;C11;3-alpha-HSD;CDR;MGC22581
NR3C1;nuclear receptor subfamily 3 group C member 1;NR3C1;GRL;nuclear receptor subfamily 3, group C, member 1;nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor);GR
PLCÎ³1
PLCG1;phospholipase C gamma 1;PLCG1;PLC1;phospholipase C, gamma 1 (formerly subtype 148);phospholipase C, gamma 1;PLC148;PLC-II;PLCgamma1;NCKAP3
NR2B1;retinoid X receptor alpha;RXRA;retinoid X receptor, alpha;NR2B1
NR2B2;retinoid X receptor beta;RXRB;retinoid X receptor, beta;NR2B2;H-2RIIBP;RCoR-1
NR2B3;retinoid X receptor gamma;RXRG;retinoid X receptor, gamma;NR2B3
GSTM
GSTP1;glutathione S-transferase pi 1;GSTP1;FAEES3;GST3;GSTP
CYP4A
CYP3A7;cytochrome P450 family 3 subfamily A member 7;CYP3A7;cytochrome P450, subfamily IIIA, polypeptide 7;cytochrome P450, family 3, subfamily A, polypeptide 7;CP37;P450-HFLA
UGT1A3;UDP glucuronosyltransferase family 1 member A3;UGT1A3;UDP glycosyltransferase 1 family, polypeptide A3;UGT1C
UGT1A4;UDP glucuronosyltransferase family 1 member A4;UGT1A4;UDP glycosyltransferase 1 family, polypeptide A4;HUG-BR2;UGT1D
PAPSS2;3'-phosphoadenosine 5'-phosphosulfate synthase 2;PAPSS2;ATPSK2
CYP24;cytochrome P450 family 24 subfamily A member 1;CYP24A1;CYP24;cytochrome P450, subfamily XXIV (vitamin D 24-hydroxylase);cytochrome P450, family 24, subfamily A, polypeptide 1;CP24;P450-CC24
AKR1C4;aldo-keto reductase family 1 member C4;AKR1C4;CHDR;aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4);DD4;HAKRA;C11;3-alpha-HSD;CDR;MGC22581
AHR;aryl hydrocarbon receptor;AHR;bHLHe76
ARNT;aryl hydrocarbon receptor nuclear translocator;ARNT;HIF-1beta;bHLHe2
NR1I3;nuclear receptor subfamily 1 group I member 3;NR1I3;nuclear receptor subfamily 1, group I, member 3;MB67;CAR1;CAR
NR1H4;nuclear receptor subfamily 1 group H member 4;NR1H4;nuclear receptor subfamily 1, group H, member 4;FXR;RIP14;HRR1;HRR-1
NR3C1;nuclear receptor subfamily 3 group C member 1;NR3C1;GRL;nuclear receptor subfamily 3, group C, member 1;nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor);GR
HNF1A;HNF1 homeobox A;HNF1A;MODY3;TCF1;transcription factor 1, hepatic; LF-B1, hepatic nuclear factor (HNF1), albumin proximal factor;HNF1;LFB1
HNF4A      ;hepatocyte nuclear factor 4 alpha;HNF4A;TCF14;MODY;MODY1;NR2A1;HNF4
NR5A2;nuclear receptor subfamily 5 group A member 2;NR5A2;FTF;nuclear receptor subfamily 5, group A, member 2;FTZ-F1beta;hB1F;LRH-1;FTZ-F1;hB1F-2;B1F2
NR1H2;nuclear receptor subfamily 1 group H member 2;NR1H2;UNR;ubiquitously-expressed nuclear receptor;nuclear receptor subfamily 1, group H, member 2;NER;NER-I;RIP15;LXR-b
NR1H3;nuclear receptor subfamily 1 group H member 3;NR1H3;nuclear receptor subfamily 1, group H, member 3;LXR-a;RLD-1
NFE2L2;nuclear factor, erythroid 2 like 2;NFE2L2;nuclear factor (erythroid-derived 2)-like 2;nuclear factor, erythroid 2-like 2;NRF2
NR0B2;nuclear receptor subfamily 0 group B member 2;NR0B2;nuclear receptor subfamily 0, group B, member 2;SHP
THRA;thyroid hormone receptor, alpha;THRA;THRA1;THRA2;ERBA1;thyroid hormone receptor, alpha (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog);thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian);EAR-7.1/EAR-7.2;THRA3;AR7;ERBA;NR1A1
THRB;thyroid hormone receptor beta;THRB;ERBA2;PRTH;thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog 2);pituitary resistance to thyroid hormone;thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian);thyroid hormone receptor, beta;THRB1;THRB2;NR1A2;THR1;ERBA-BETA;GRTH
RARA;retinoic acid receptor alpha;RARA;retinoic acid receptor, alpha;RAR;NR1B1
RARB;retinoic acid receptor beta;RARB;retinoic acid receptor, beta;HAP;NR1B2;RRB2
RARG;retinoic acid receptor gamma;RARG;retinoic acid receptor, gamma;RARC;NR1B3
PPARA;peroxisome proliferator activated receptor alpha;PPARA;PPAR;peroxisome proliferative activated receptor, alpha;peroxisome proliferator-activated receptor alpha;hPPAR;NR1C1
PPARD;peroxisome proliferator activated receptor delta;PPARD;peroxisome proliferative activated receptor, delta;peroxisome proliferator-activated receptor delta;NUC1;NUCII;FAAR;NR1C2
PPARB
PPARG;peroxisome proliferator activated receptor gamma;PPARG;peroxisome proliferative activated receptor, gamma;peroxisome proliferator-activated receptor gamma;PPARG1;PPARG2;NR1C3;PPARgamma
NR1I2;nuclear receptor subfamily 1 group I member 2;NR1I2;nuclear receptor subfamily 1, group I, member 2;ONR1;PXR;BXR;SXR;PAR2
VDR;vitamin D (1,25- dihydroxyvitamin D3) receptor;VDR;NR1I1;PPP1R163
ALAS1;5'-aminolevulinate synthase 1;ALAS1;ALAS3;ALAS;aminolevulinate, delta-, synthase 1
CYP1A1;cytochrome P450 family 1 subfamily A member 1;CYP1A1;CYP1;cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 1;cytochrome P450, family 1, subfamily A, polypeptide 1;P450DX;P1-450;P450-C;CP11
CYP1A2;cytochrome P450 family 1 subfamily A member 2;CYP1A2;cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 2;cytochrome P450, family 1, subfamily A, polypeptide 2;P3-450;CP12
CYP1B1;cytochrome P450 family 1 subfamily B member 1;CYP1B1;GLC3A;cytochrome P450, subfamily I (dioxin-inducible), polypeptide 1 (glaucoma 3, primary infantile);cytochrome P450, family 1, subfamily B, polypeptide 1;CP1B
CYP2A6;cytochrome P450 family 2 subfamily A member 6;CYP2A6;CYP2A3;cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 6;cytochrome P450, family 2, subfamily A, polypeptide 6;CPA6;CYP2A
CYP2B1
CYP2B2
SLCO1A2;solute carrier organic anion transporter family member 1A2;SLCO1A2;SLC21A3;solute carrier family 21 (organic anion transporter), member 3;solute carrier organic anion transporter family, member 1A2;OATP;OATP1A2;OATP-A
cyp2b6;cytochrome P450 family 2 subfamily B member 6;CYP2B6;CYP2B;cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 6;cytochrome P450, family 2, subfamily B;cytochrome P450, subfamily IIB (phenobarbital-inducible);cytochrome P450, family 2, subfamily B, polypeptide 6;CPB6;CYPIIB6
cyp2c9;cytochrome P450 family 2 subfamily C member 9;CYP2C9;CYP2C10;cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 9;cytochrome P450, family 2, subfamily C, polypeptide 9;P450IIC9
cyp2c19;cytochrome P450 family 2 subfamily C member 19;CYP2C19;CYP2C;cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 19;cytochrome P450, family 2, subfamily C, polypeptide 19;P450IIC19;CPCJ
cyp2d6;cytochrome P450 family 2 subfamily D member 6;CYP2D6;CYP2DL1;CYP2D7P2;CYP2D7BP;CYP2D8P2;CYP2D7AP;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6;cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2;cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 6;CPD6;P450-DB1;CYP2D;P450C2D
cyp3a4;cytochrome P450 family 3 subfamily A member 4;CYP3A4;CYP3A3;cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4;cytochrome P450, family 3, subfamily A, polypeptide 4
cyp3a5;cytochrome P450 family 3 subfamily A member 5;CYP3A5;cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 5;cytochrome P450, family 3, subfamily A, polypeptide 5;PCN3;P450PCN3;CP35
cyp7a1;cytochrome P450 family 7 subfamily A member 1;CYP7A1;CYP7;cytochrome P450, subfamily VIIA (cholesterol 7 alpha-monooxygenase), polypeptide 1;cytochrome P450, family 7, subfamily A, polypeptide 1
gsta1;glutathione S-transferase alpha 1;GSTA1;glutathione S-transferase A1
nqo1;NAD(P)H quinone dehydrogenase 1;NQO1;NMOR1;DIA4;diaphorase (NADH/NADPH) (cytochrome b-5 reductase);NAD(P)H dehydrogenase, quinone 1;DHQU;QR1;DTD
ugt1a1;UDP glucuronosyltransferase family 1 member A1;UGT1A1;UGT1;GNT1;UDP glycosyltransferase 1 family, polypeptide A1;UGT1A
ugt1a6;UDP glucuronosyltransferase family 1 member A6;UGT1A6;UDP glycosyltransferase 1 family, polypeptide A6;HLUGP;GNT1;UGT1F
ugt1a8;UDP glucuronosyltransferase family 1 member A8;UGT1A8;UDP glycosyltransferase 1 family, polypeptide A8;UGT1H
ugt1a9;UDP glucuronosyltransferase family 1 member A9;UGT1A9;UDP glycosyltransferase 1 family, polypeptide A9;HLUGP4;LUGP4;UGT1AI
ugt1a10;UDP glucuronosyltransferase family 1 member A10;UGT1A10;UDP glycosyltransferase 1 family, polypeptide A10;UGT1J
ugt2b4;UDP glucuronosyltransferase family 2 member B4;UGT2B4;UDP glycosyltransferase 2 family, polypeptide B4;UGT2B11
sult2a1;sulfotransferase family 2A member 1;SULT2A1;STD;sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1;DHEA-ST
abca1;ATP binding cassette subfamily A member 1;ABCA1;ABC1;HDLDT1;ATP-binding cassette, sub-family A (ABC1), member 1;TGD
ABCG5;ATP binding cassette subfamily G member 5;ABCG5;ATP-binding cassette, sub-family G (WHITE), member 5;STSL
ABCG8;ATP binding cassette subfamily G member 8;ABCG8;ATP-binding cassette, sub-family G (WHITE), member 8 (sterolin 2);ATP-binding cassette, sub-family G (WHITE), member 8;GBD4
ABCG1;ATP binding cassette subfamily G member 1;ABCG1;ATP-binding cassette, sub-family G (WHITE), member 1;ABC8
SLC10A2;solute carrier family 10 member 2;SLC10A2;ASBT;ISBT;solute carrier family 10 (sodium/bile acid cotransporter), member 2
ABCB11;ATP binding cassette subfamily B member 11;ABCB11;BSEP;PFIC2;progressive familial intrahepatic cholestasis 2;bile salt export pump;ATP-binding cassette, sub-family B (MDR/TAP), member 11;ABC16;SPGP;PFIC-2;PGY4
FABP6;fatty acid binding protein 6;FABP6;fatty acid binding protein 6, ileal;I-15P;ILLBP;I-BAP;ILBP3;I-BABP;ILBP;I-BALB
FXR;nuclear receptor subfamily 1 group H member 4;NR1H4;nuclear receptor subfamily 1, group H, member 4;FXR;RIP14;HRR1;HRR-1
ABCB1;ATP binding cassette subfamily B member 1;ABCB1;PGY1;MDR1;CLCS;colchicin sensitivity;ATP-binding cassette, sub-family B (MDR/TAP), member 1;P-gp;CD243;GP170;ABC20
ABCB4;ATP binding cassette subfamily B member 4;ABCB4;PGY3;MDR3;ATP-binding cassette, sub-family B (MDR/TAP), member 4;MDR2;PFIC-3;GBD1
ABCC1;ATP binding cassette subfamily C member 1;ABCC1;MRP;MRP1;multidrug resistance associated protein 1;ATP-binding cassette, sub-family C (CFTR/MRP), member 1;GS-X
ABCC2;ATP binding cassette subfamily C member 2;ABCC2;CMOAT;canalicular multispecific organic anion transporter 1;ATP-binding cassette, sub-family C (CFTR/MRP), member 2;DJS;MRP2;cMRP
ABCC3;ATP binding cassette subfamily C member 3;ABCC3;ATP-binding cassette, sub-family C (CFTR/MRP), member 3;MRP3;cMOAT2;EST90757;MLP2;MOAT-D
ABCC4;ATP binding cassette subfamily C member 4;ABCC4;ATP-binding cassette, sub-family C (CFTR/MRP), member 4;MRP4;EST170205;MOAT-B;MOATB
SLCO1B1;solute carrier organic anion transporter family member 1B1;SLCO1B1;SLC21A6;solute carrier family 21 (organic anion transporter), member 6;solute carrier organic anion transporter family, member 1B1;OATP-C;LST-1;OATP1B1
SLCO1B3;solute carrier organic anion transporter family member 1B3;SLCO1B3;SLC21A8;solute carrier family 21 (organic anion transporter), member 8;solute carrier organic anion transporter family, member 1B3;OATP8;OATP1B3
CDXA
MYOD;MyoD family inhibitor;MDFI;I-mfa
SRY;sex determining region Y;SRY;TDF
HNF3B;forkhead box A2;FOXA2;HNF3B;hepatocyte nuclear factor 3, beta
AML1;runt related transcription factor 1;RUNX1;AML1;CBFA2;acute myeloid leukemia 1;runt-related transcription factor 1;PEBP2A2;AMLCR1
Sensor protein CpxA;neuronal calcium sensor 1;NCS1;FREQ;frequenin (Drosophila) homolog;frequenin homolog (Drosophila);NCS-1
5'-D(*CP*CP*TP*GP*CP*AP*CP*AP*AP*AP*CP*AP*CP*C)-3';ATP binding cassette subfamily D member 1 pseudogene 5;ABCD1P5;ATP-binding cassette, sub-family D (ALD), member 1, pseudogene 5
5'-D(*GP*GP*TP*GP*TP*TP*TP*GP*TP*GP*CP*AP*GP*G)-3';ATP binding cassette subfamily D member 1 pseudogene 5;ABCD1P5;ATP-binding cassette, sub-family D (ALD), member 1, pseudogene 5
SEX-DETERMINING REGION Y PROTEIN
Hepatocyte nuclear factor 1-beta;hepatocyte nuclear factor 4 gamma pseudogene 1;HNF4GP1
CORE-BINDING FACTOR ALPHA SUBUNIT;core-binding factor beta subunit;CBFB;core-binding factor, beta subunit;PEBP2B
CORE-BINDING FACTOR CBF-BETA;core-binding factor beta subunit;CBFB;core-binding factor, beta subunit;PEBP2B
Neuronal calcium sensor 1;neuronal calcium sensor 1;NCS1;FREQ;frequenin (Drosophila) homolog;frequenin homolog (Drosophila);NCS-1
5'-D(*CP*CP*TP*GP*CP*AP*CP*AP*AP*AP*CP*AP*CP*C)-3';ATP binding cassette subfamily D member 1 pseudogene 5;ABCD1P5;ATP-binding cassette, sub-family D (ALD), member 1, pseudogene 5
5'-D(*GP*GP*TP*GP*TP*TP*TP*GP*TP*GP*CP*AP*GP*G)-3';ATP binding cassette subfamily D member 1 pseudogene 5;ABCD1P5;ATP-binding cassette, sub-family D (ALD), member 1, pseudogene 5
SEX-DETERMINING REGION Y PROTEIN
CORE-BINDING FACTOR;core-binding factor beta subunit;CBFB;core-binding factor, beta subunit;PEBP2B
Cytochrome P450 7A1;cytochrome c oxidase subunit 7A1;COX7A1;COX7A;cytochrome c oxidase subunit VIIa polypeptide 1 (muscle);COX7AH
RBMA
Cytochrome P450 1B1;cytochrome P450 family 2 subfamily D member 6;CYP2D6;CYP2DL1;CYP2D7P2;CYP2D7BP;CYP2D8P2;CYP2D7AP;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6;cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2;cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 6;CPD6;P450-DB1;CYP2D;P450C2D
Vitamin D3 receptor;vitamin D (1,25- dihydroxyvitamin D3) receptor;VDR;NR1I1;PPP1R163
Epidermal growth factor receptor;epidermal growth factor receptor;EGFR;ERBB;epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b) oncogene homolog);ERBB1
Cytochrome P-450;cytochrome b5 reductase 1;CYB5R1;NQO3A2;NAD(P)H:quinone oxidoreductase type 3, polypeptide A2;humb5R2
Bile acid-coenzyme A ligase;bile acid-CoA:amino acid N-acyltransferase;BAAT;bile acid Coenzyme A:amino acid N-acyltransferase (glycine N-choloyltransferase);bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase);BAT
Vitamin D3 receptor A;vitamin D (1,25- dihydroxyvitamin D3) receptor;VDR;NR1I1;PPP1R163
Nuclear receptor coactivator 2;RNA, U1 small nuclear 4;RNU1-4;RNU1E2;RNU1G2;RNU1D2;RNU1F1;RNU1G1;RNA, U1E2 small nuclear;RNA, U1G2 small nuclear;RNA, U1D2 small nuclear;RNA, U1F1 small nuclear;RNA, U1G1 small nuclear;HSD6;U1E2;HSD2;U1D2;HSD5;U1B2;U1F;HSD7
Fatty acid-binding protein, liver;fatty acid binding protein 1;FABP1;fatty acid binding protein 1, liver;L-FABP
NR1H4;nuclear receptor subfamily 1 group H member 4;NR1H4;nuclear receptor subfamily 1, group H, member 4;FXR;RIP14;HRR1;HRR-1
12-meric peptide from Nuclear receptor coactivator 1;RNA, U1 small nuclear 4;RNU1-4;RNU1E2;RNU1G2;RNU1D2;RNU1F1;RNU1G1;RNA, U1E2 small nuclear;RNA, U1G2 small nuclear;RNA, U1D2 small nuclear;RNA, U1F1 small nuclear;RNA, U1G1 small nuclear;HSD6;U1E2;HSD2;U1D2;HSD5;U1B2;U1F;HSD7
GLUCOCORTICOID RECEPTOR;nuclear receptor subfamily 3 group C member 1;NR3C1;GRL;nuclear receptor subfamily 3, group C, member 1;nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor);GR
Protein KES1;G protein subunit alpha q pseudogene 1;GNAQP1;GNAQP;quanine nucleotide binding protein (G protein), q polypeptide pseudogene;guanine nucleotide binding protein (G protein), q polypeptide pseudogene;guanine nucleotide binding protein (G protein), q polypeptide pseudogene 1
Oxysterols receptor LXR-beta;cholinergic receptor nicotinic beta 1 subunit;CHRNB1;CHRNB;cholinergic receptor, nicotinic, beta polypeptide 1 (muscle);cholinergic receptor, nicotinic, beta 1 (muscle);cholinergic receptor, nicotinic beta 1
Nuclear receptor ROR-gamma;retinoid X receptor gamma;RXRG;retinoid X receptor, gamma;NR2B3
Beta-parvin;parvin beta;PARVB;CGI-56
Paxillin;paxillin;PXN
P-site tRNA fMet;tRNA methyltransferase 10C, mitochondrial RNase P subunit;TRMT10C;RG9MTD1;RNA (guanine-9-) methyltransferase domain containing 1;tRNA methyltransferase 10 homolog C (S. cerevisiae);FLJ20432;MRPP1
A-site ASL SufA6;argininosuccinate lyase;ASL
messenger RNA;CDKN2B antisense RNA 1;CDKN2B-AS1;CDKN2B antisense RNA 1 (non-protein coding);ANRIL;CDKN2BAS;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12
tRNA acceptor end mimic;Rab acceptor 1;RABAC1;Rab acceptor 1 (prenylated);PRA1;PRAF1;YIP3
RNA (5'-R(*CP*CP*(PPU))-3');regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1;RIIAD1;NCRNA00166;C1orf230;non-protein coding RNA 166;chromosome 1 open reading frame 230;FLJ36032
PTERIDINE REDUCTASE;glyoxylate and hydroxypyruvate reductase;GRHPR;GLXR;glyoxylate reductase/hydroxypyruvate reductase;glyoxylate reductase and hydroxypyruvate reductase;PH2
PTERIDINE REDUCTASE;glyoxylate and hydroxypyruvate reductase;GRHPR;GLXR;glyoxylate reductase/hydroxypyruvate reductase;glyoxylate reductase and hydroxypyruvate reductase;PH2
ALCOHOL SULFOTRANSFERASE;alcohol dehydrogenase 1A (class I), alpha polypeptide;ADH1A;ADH1
INTESTINAL FATTY ACID BINDING PROTEIN;bile acid-CoA:amino acid N-acyltransferase;BAAT;bile acid Coenzyme A:amino acid N-acyltransferase (glycine N-choloyltransferase);bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase);BAT
Phosphoenolpyruvate synthase;phosphoenolpyruvate carboxykinase 1;PCK1;phosphoenolpyruvate carboxykinase 1 (soluble);PEPCK-C
B-CELL LYMPHOMA 6 PROTEIN;B-cell CLL/lymphoma 6;BCL6;ZNF51;zinc finger protein 51;ZBTB27;LAZ3;BCL5;BCL6A
Orphan Nuclear Receptor PXR;nuclear receptor subfamily 1 group I member 2;NR1I2;nuclear receptor subfamily 1, group I, member 2;ONR1;PXR;BXR;SXR;PAR2
Tubulin alpha chain;alpha tubulin acetyltransferase 1;ATAT1;C6orf134;chromosome 6 open reading frame 134;FLJ13158;Em:AB023049.7;MEC17
Tubulin beta chain;tubulin beta class I;TUBB;tubulin, beta polypeptide;tubulin, beta;tubulin, beta class I;OK/SW-cl.56;MGC16435;M40;Tubb5
Kinesin-like protein KIF1A;kinesin family member 1A;KIF1A;ATSV;C2orf20;SPG30;axonal transport of synaptic vesicles;chromosome 2 open reading frame 20;spastic paraplegia 30 (autosomal recessive);UNC104
Cytochrome P450 3A4;cytochrome P450 family 2 subfamily D member 6;CYP2D6;CYP2DL1;CYP2D7P2;CYP2D7BP;CYP2D8P2;CYP2D7AP;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6;cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2;cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 6;CPD6;P450-DB1;CYP2D;P450C2D
Protease;protease associated domain containing 1;PRADC1;C2orf7;chromosome 2 open reading frame 7;MGC13004;PAP21;hPAP21
HIV-1 Protease;HIV-1 Tat specific factor 1 pseudogene 1;HTATSF1P1;HTATSF1P;HIV TAT specific factor 1 pseudogene;HIV-1 Tat specific factor 1 pseudogene;TAT-SF1-L;dJ1033B10.6
p1-p6 peptide;natriuretic peptide receptor 3;NPR3;NPRC;ANPRC;C5orf23;chromosome 5 open reading frame 23;atrionatriuretic peptide receptor C;natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C);natriuretic peptide receptor C;GUCY2B;FLJ14054
HIV-1 RT, A-CHAIN;HIV-1 Tat interactive protein 2;HTATIP2;HIV-1 Tat interactive protein 2, 30 kDa;HIV-1 Tat interactive protein 2, 30kDa;TIP30;CC3;FLJ26963;SDR44U1
HIV-1 RT, B-CHAIN;HIV-1 Tat interactive protein 2;HTATIP2;HIV-1 Tat interactive protein 2, 30 kDa;HIV-1 Tat interactive protein 2, 30kDa;TIP30;CC3;FLJ26963;SDR44U1
Enoyl reductase;mitochondrial trans-2-enoyl-CoA reductase;MECR;CGI-63;NRBF1;FASN2B
Transesterase
CYTOCHROME P450 2C8;cytochrome P450 family 2 subfamily D member 6;CYP2D6;CYP2DL1;CYP2D7P2;CYP2D7BP;CYP2D8P2;CYP2D7AP;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6;cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2;cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 6;CPD6;P450-DB1;CYP2D;P450C2D
Vitamin B12 transport protein btuF;transcobalamin 1;TCN1;transcobalamin I (vitamin B12 binding protein, R binder family);transcobalamin I;TCI;TC1
menB
Mineralocorticoid receptor;calcitonin receptor like receptor;CALCRL;calcitonin receptor-like;CGRPR;CRLR
Glycogen phosphorylase, muscle form;phosphorylase, glycogen, muscle;PYGM;phosphorylase, glycogen; muscle
5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-3';ATP binding cassette subfamily D member 1 pseudogene 5;ABCD1P5;ATP-binding cassette, sub-family D (ALD), member 1, pseudogene 5
5'-D(*(TGP)P*GP*AP*AP*AP*AP*AP*TP*TP*TP*TP*T)-3';ATP binding cassette subfamily D member 1 pseudogene 5;ABCD1P5;ATP-binding cassette, sub-family D (ALD), member 1, pseudogene 5
5'-D(*AP*AP*AP*AP*AP*TP*TP*TP*TP*TP*CP*CP*AP*AP*GP*TP*CP*TP*TP*TP*TP*T)-3';ATP binding cassette subfamily D member 1 pseudogene 5;ABCD1P5;ATP-binding cassette, sub-family D (ALD), member 1, pseudogene 5
Biphenyl dioxygenase subunit alpha;prolyl 4-hydroxylase subunit alpha 1;P4HA1;P4HA;procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide I;prolyl 4-hydroxylase, alpha polypeptide I;C-P4Halpha(I)
Biphenyl dioxygenase subunit beta;prolyl 4-hydroxylase subunit beta;P4HB;PO4DB;ERBA2L;procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptide (protein disulfide isomerase; thyroid hormone binding protein p55);procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptide (protein disulfide isomerase-associated 1);procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptide;prolyl 4-hydroxylase, beta polypeptide;PDIA1;PROHB;DSI;GIT;PDI;PO4HB;P4Hbeta
NADPH-P450 reductase;methylenetetrahydrofolate reductase;MTHFR;5,10-methylenetetrahydrofolate reductase (NADPH);methylenetetrahydrofolate reductase (NAD(P)H)
NADPH-P450 reductase;methylenetetrahydrofolate reductase;MTHFR;5,10-methylenetetrahydrofolate reductase (NADPH);methylenetetrahydrofolate reductase (NAD(P)H);5,10-methylenetetrahydrofolate reductase (NADPH);methylenetetrahydrofolate reductase (NAD(P)H)
23S RIBOSOMAL RNA;RNA, 5S ribosomal pseudogene 57;RNA5SP57;RN5S57;RNA5SP58;RN5S58;RNA, 5S ribosomal 57;RNA, 5S ribosomal pseudogene 58;RNA, 5S ribosomal 58
50S ribosomal protein L22;mitochondrial ribosomal protein L22;MRPL22;MRP-L25;RPML25;HSPC158
50S ribosomal protein L32;mitochondrial ribosomal protein L32;MRPL32;HSPC283;L32mt;MRP-L32;bMRP-59b
Ancestral Steroid Receptor 2;hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2;HSD3B2;SDR11E2
Chimeric antibody Fab 1E9, light chain;myosin light chain kinase pseudogene 1;MYLKP1;MYLKP;myosin, light polypeptide kinase pseudogene;myosin light chain kinase pseudogene;myosin light chain kinase pseudogene 1;myosin light chain kinase pseudogene 1 (functional)
Chimeric antibody Fab 1E9, heavy chain;solute carrier family 3 member 2;SLC3A2;MDU1;solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2;solute carrier family 3 (amino acid transporter heavy chain), member 2;4T2HC;4F2;NACAE;CD98;CD98HC;4F2HC
Beta-lactoglobulin;mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase;MGAT3;GNT-III
VITAMIN D3 RECEPTOR;vitamin D (1,25- dihydroxyvitamin D3) receptor;VDR;NR1I1;PPP1R163
Vitamin D receptor;mediator complex subunit 4;MED4;VDRIP;vitamin D receptor interacting protein;mediator of RNA polymerase II transcription, subunit 4 homolog (S. cerevisiae);HSPC126;DRIP36;TRAP36
SRC-1 from Nuclear receptor coactivator 1;RNA, U1 small nuclear 4;RNU1-4;RNU1E2;RNU1G2;RNU1D2;RNU1F1;RNU1G1;RNA, U1E2 small nuclear;RNA, U1G2 small nuclear;RNA, U1D2 small nuclear;RNA, U1F1 small nuclear;RNA, U1G1 small nuclear;HSD6;U1E2;HSD2;U1D2;HSD5;U1B2;U1F;HSD7
CELLULAR RETINOIC ACID BINDING PROTEIN TYPE II;RANBP2-type and C3HC4-type zinc finger containing 1;RBCK1;C20orf18;chromosome 20 open reading frame 18;RanBP-type and C3HC4-type zinc finger containing 1;RBCK2;XAP4;RNF54;ZRANB4;UBCE7IP3;HOIL1
constitutive androstane receptor;nuclear receptor subfamily 1 group I member 3;NR1I3;nuclear receptor subfamily 1, group I, member 3;MB67;CAR1;CAR
FK506 BINDING PROTEIN;FK506 binding protein 1A;FKBP1A;FKBP1;FK506-binding protein 1A (12kD);FK506 binding protein 1A, 12kDa;FKBP-12;FKBP12;PKC12;PPIASE;FKBP12C
Apolipoprotein A-I;apolipoprotein A1;APOA1;apolipoprotein A-I
LOW-DENSITY LIPOPROTEIN RECEPTOR;low density lipoprotein receptor class A domain containing 1;LDLRAD1;low density lipoprotein receptor A domain containing 1
Glucocorticoid receptor;nuclear receptor subfamily 3 group C member 1;NR3C1;GRL;nuclear receptor subfamily 3, group C, member 1;nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor);GR
Nuclear receptor coactivator 2 peptide;RNA, U1 small nuclear 4;RNU1-4;RNU1E2;RNU1G2;RNU1D2;RNU1F1;RNU1G1;RNA, U1E2 small nuclear;RNA, U1G2 small nuclear;RNA, U1D2 small nuclear;RNA, U1F1 small nuclear;RNA, U1G1 small nuclear;HSD6;U1E2;HSD2;U1D2;HSD5;U1B2;U1F;HSD7
PHOSPHOLIPASE C-BETA (PLC-BETA);phospholipase C beta 1;PLCB1;phospholipase C, beta 1 (phosphoinositide-specific);KIAA0581;PLC-I;PLC154
Basic fibroblast growth factor receptor 1;fibroblast growth factor receptor 1;FGFR1;FLT2;KAL2;fms-related tyrosine kinase 2;H2;H3;H4;H5;CEK;FLG;BFGFR;N-SAM;CD331
Phospholipase C-gamma-1;phospholipase C gamma 1;PLCG1;PLC1;phospholipase C, gamma 1 (formerly subtype 148);phospholipase C, gamma 1;PLC148;PLC-II;PLCgamma1;NCKAP3
Nuclear receptor coactivator 2;RNA, U1 small nuclear 4;RNU1-4;RNU1E2;RNU1G2;RNU1D2;RNU1F1;RNU1G1;RNA, U1E2 small nuclear;RNA, U1G2 small nuclear;RNA, U1D2 small nuclear;RNA, U1F1 small nuclear;RNA, U1G1 small nuclear;HSD6;U1E2;HSD2;U1D2;HSD5;U1B2;U1F;HSD7
Glutamate [NMDA] receptor subunit epsilon-2;glutamate ionotropic receptor NMDA type subunit 1;GRIN1;NMDAR1;N-methyl-D-aspartate receptor subunit NR1;glutamate receptor, ionotropic, N-methyl D-aspartate 1;GluN1
Glutathione S-transferase Mu 2;glutathione S-transferase mu 2;GSTM2;glutathione S-transferase M2 (muscle);glutathione S-transferase mu 2 (muscle);GST4
Glutathione S-transferase P;glutathione S-transferase alpha 1;GSTA1;glutathione S-transferase A1
Cytochrome P450 74A2;cytochrome P450 family 2 subfamily D member 6;CYP2D6;CYP2DL1;CYP2D7P2;CYP2D7BP;CYP2D8P2;CYP2D7AP;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6;cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2;cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 6;CPD6;P450-DB1;CYP2D;P450C2D
CYTOCHROME P450 3A4;cytochrome P450 family 2 subfamily D member 6;CYP2D6;CYP2DL1;CYP2D7P2;CYP2D7BP;CYP2D8P2;CYP2D7AP;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6;cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2;cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 6;CPD6;P450-DB1;CYP2D;P450C2D
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial;thioredoxin interacting protein;TXNIP;VDUP1;EST01027;HHCPA78;THIF;ARRDC6
Aryl hydrocarbon receptor;aryl hydrocarbon receptor interacting protein like 1;AIPL1;LCA4;aryl hydrocarbon receptor-interacting protein-like 1;aryl hydrocarbon receptor interacting protein-like 1
Aryl hydrocarbon receptor nuclear translocator;aryl hydrocarbon receptor nuclear translocator;ARNT;HIF-1beta;bHLHe2
Transforming acidic coiled-coil-containing protein 3;transforming acidic coiled-coil containing protein 3;TACC3;transforming, acidic coiled-coil containing protein 3;ERIC1
constitutive androstane receptor;nuclear receptor subfamily 1 group I member 3;NR1I3;nuclear receptor subfamily 1, group I, member 3;MB67;CAR1;CAR
Farnesoid X receptor;nuclear receptor subfamily 1 group H member 4;NR1H4;nuclear receptor subfamily 1, group H, member 4;FXR;RIP14;HRR1;HRR-1
5'-D(*CP*TP*TP*GP*GP*TP*TP*AP*AP*TP*AP*AP*TP*TP*CP*AP*CP*CP*AP*GP*A)-3';ATP binding cassette subfamily D member 1 pseudogene 5;ABCD1P5;ATP-binding cassette, sub-family D (ALD), member 1, pseudogene 5
5'-D(*TP*CP*TP*GP*GP*TP*GP*AP*AP*TP*TP*AP*TP*TP*AP*AP*CP*CP*AP*AP*G)-3';ATP binding cassette subfamily D member 1 pseudogene 5;ABCD1P5;ATP-binding cassette, sub-family D (ALD), member 1, pseudogene 5
HEPATOCYTE NUCLEAR FACTOR 1-ALPHA;pterin-4 alpha-carbinolamine dehydratase 1;PCBD1;DCOH;PCBD;6-pyruvoyl-tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1);pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1);pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha;PCD
Hepatocyte nuclear factor 4-alpha;hepatocyte nuclear factor 4 alpha;HNF4A;TCF14;MODY;MODY1;NR2A1;HNF4
PPARgamma Coactivator-1a (PGC-1a);PPARG coactivator 1 alpha;PPARGC1A;PPARGC1;peroxisome proliferative activated receptor, gamma, coactivator 1;peroxisome proliferative activated receptor, gamma, coactivator 1, alpha;peroxisome proliferator-activated receptor gamma, coactivator 1 alpha;PGC1;PGC1A;PGC-1alpha
FTZ-F1 related protein;LDL receptor related protein associated protein 1;LRPAP1;A2MRAP;low density lipoprotein-related protein-associated protein 1 (alpha-2-macroglobulin receptor-associated protein 1);low density lipoprotein receptor-related protein associated protein 1;HBP44
Nuclear receptor coactivator 2;RNA, U1 small nuclear 4;RNU1-4;RNU1E2;RNU1G2;RNU1D2;RNU1F1;RNU1G1;RNA, U1E2 small nuclear;RNA, U1G2 small nuclear;RNA, U1D2 small nuclear;RNA, U1F1 small nuclear;RNA, U1G1 small nuclear;HSD6;U1E2;HSD2;U1D2;HSD5;U1B2;U1F;HSD7
Oxysterols receptor LXR-beta;cholinergic receptor nicotinic beta 1 subunit;CHRNB1;CHRNB;cholinergic receptor, nicotinic, beta polypeptide 1 (muscle);cholinergic receptor, nicotinic, beta 1 (muscle);cholinergic receptor, nicotinic beta 1
Nuclear receptor coactivator 2;RNA, U1 small nuclear 4;RNU1-4;RNU1E2;RNU1G2;RNU1D2;RNU1F1;RNU1G1;RNA, U1E2 small nuclear;RNA, U1G2 small nuclear;RNA, U1D2 small nuclear;RNA, U1F1 small nuclear;RNA, U1G1 small nuclear;HSD6;U1E2;HSD2;U1D2;HSD5;U1B2;U1F;HSD7
Oxysterols receptor LXR-alpha;interferon lambda receptor 1;IFNLR1;IL28RA;interleukin 28 receptor, alpha;interleukin 28 receptor, alpha (interferon, lambda receptor);interferon, lambda receptor 1;CRF2/12;IFNLR;IL-28R1
Nuclear receptor coactivator 1;RNA, U1 small nuclear 4;RNU1-4;RNU1E2;RNU1G2;RNU1D2;RNU1F1;RNU1G1;RNA, U1E2 small nuclear;RNA, U1G2 small nuclear;RNA, U1D2 small nuclear;RNA, U1F1 small nuclear;RNA, U1G1 small nuclear;HSD6;U1E2;HSD2;U1D2;HSD5;U1B2;U1F;HSD7
Nuclear receptor subfamily 5 group A member 2;nuclear receptor subfamily 5 group A member 2;NR5A2;FTF;nuclear receptor subfamily 5, group A, member 2;FTZ-F1beta;hB1F;LRH-1;FTZ-F1;hB1F-2;B1F2
Nuclear receptor subfamily 0 group B member 2;nuclear receptor subfamily 0 group B member 2;NR0B2;nuclear receptor subfamily 0, group B, member 2;SHP
THRA protein;thyroid hormone receptor, alpha;THRA;THRA1;THRA2;ERBA1;thyroid hormone receptor, alpha (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog);thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian);EAR-7.1/EAR-7.2;THRA3;AR7;ERBA;NR1A1
Homoserine kinase;mitogen-activated protein kinase kinase kinase kinase 1;MAP4K1;HPK1
P-site tRNA fMet;tRNA methyltransferase 10C, mitochondrial RNase P subunit;TRMT10C;RG9MTD1;RNA (guanine-9-) methyltransferase domain containing 1;tRNA methyltransferase 10 homolog C (S. cerevisiae);FLJ20432;MRPP1
A-site ASL SufA6;argininosuccinate lyase;ASL
messenger RNA;CDKN2B antisense RNA 1;CDKN2B-AS1;CDKN2B antisense RNA 1 (non-protein coding);ANRIL;CDKN2BAS;RP11-145E5.4;NCRNA00089;p15AS;CDKN2B-AS;PCAT12
tRNA acceptor end mimic;Rab acceptor 1;RABAC1;Rab acceptor 1 (prenylated);PRA1;PRAF1;YIP3
RNA (5'-R(*CP*CP*(PPU))-3');regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1;RIIAD1;NCRNA00166;C1orf230;non-protein coding RNA 166;chromosome 1 open reading frame 230;FLJ36032
Nuclear receptor coactivator 1;RNA, U1 small nuclear 4;RNU1-4;RNU1E2;RNU1G2;RNU1D2;RNU1F1;RNU1G1;RNA, U1E2 small nuclear;RNA, U1G2 small nuclear;RNA, U1D2 small nuclear;RNA, U1F1 small nuclear;RNA, U1G1 small nuclear;HSD6;U1E2;HSD2;U1D2;HSD5;U1B2;U1F;HSD7
Peroxisome proliferator-activated receptor alpha;peroxisome proliferator activated receptor alpha;PPARA;PPAR;peroxisome proliferative activated receptor, alpha;peroxisome proliferator-activated receptor alpha;hPPAR;NR1C1
Peptide motif 5 of Nuclear receptor coactivator 1;RNA, U1 small nuclear 4;RNU1-4;RNU1E2;RNU1G2;RNU1D2;RNU1F1;RNU1G1;RNA, U1E2 small nuclear;RNA, U1G2 small nuclear;RNA, U1D2 small nuclear;RNA, U1F1 small nuclear;RNA, U1G1 small nuclear;HSD6;U1E2;HSD2;U1D2;HSD5;U1B2;U1F;HSD7
Peroxisome proliferator-activated receptor delta;peroxisome proliferator activated receptor delta;PPARD;peroxisome proliferative activated receptor, delta;peroxisome proliferator-activated receptor delta;NUC1;NUCII;FAAR;NR1C2
Peroxisome proliferator-activated receptor delta;peroxisome proliferator activated receptor delta;PPARD;peroxisome proliferative activated receptor, delta;peroxisome proliferator-activated receptor delta;NUC1;NUCII;FAAR;NR1C2
Peroxisome proliferator-activated receptor gamma;peroxisome proliferator activated receptor gamma;PPARG;peroxisome proliferative activated receptor, gamma;peroxisome proliferator-activated receptor gamma;PPARG1;PPARG2;NR1C3;PPARgamma
Decamer from Nuclear receptor coactivator 1;RNA, U1 small nuclear 4;RNU1-4;RNU1E2;RNU1G2;RNU1D2;RNU1F1;RNU1G1;RNA, U1E2 small nuclear;RNA, U1G2 small nuclear;RNA, U1D2 small nuclear;RNA, U1F1 small nuclear;RNA, U1G1 small nuclear;HSD6;U1E2;HSD2;U1D2;HSD5;U1B2;U1F;HSD7
Pregnane X receptor, Linker, Steroid receptor coactivator 1;hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1;HSD3B1;HSDB3;HSD3B;SDR11E1
Vitamin D3 receptor;vitamin D (1,25- dihydroxyvitamin D3) receptor;VDR;NR1I1;PPP1R163
Putative uncharacterized protein TTHA1699;receptor transporter protein 5 (putative);RTP5;C2orf85;CXXC11;chromosome 2 open reading frame 85;CXXC finger protein 11;receptor (chemosensory) transporter protein 5 (putative);FLJ33590;Z3CXXC5
Cholesterol 7-alpha-monooxygenase;cytochrome P450 family 7 subfamily A member 1;CYP7A1;CYP7;cytochrome P450, subfamily VIIA (cholesterol 7 alpha-monooxygenase), polypeptide 1;cytochrome P450, family 7, subfamily A, polypeptide 1
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A;phosphodiesterase 10A;PDE10A
Cytochrome P450 1B1;cytochrome P450 family 2 subfamily D member 6;CYP2D6;CYP2DL1;CYP2D7P2;CYP2D7BP;CYP2D8P2;CYP2D7AP;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6;cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2;cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 6;CPD6;P450-DB1;CYP2D;P450C2D
Cytochrome P450 2A6;cytochrome P450 family 2 subfamily D member 6;CYP2D6;CYP2DL1;CYP2D7P2;CYP2D7BP;CYP2D8P2;CYP2D7AP;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6;cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2;cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 6;CPD6;P450-DB1;CYP2D;P450C2D
Cytochrome P450 1B1;cytochrome P450 family 2 subfamily D member 6;CYP2D6;CYP2DL1;CYP2D7P2;CYP2D7BP;CYP2D8P2;CYP2D7AP;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6;cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2;cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 6;CPD6;P450-DB1;CYP2D;P450C2D
Cytochrome P450 2B4;cytochrome P450 family 2 subfamily D member 6;CYP2D6;CYP2DL1;CYP2D7P2;CYP2D7BP;CYP2D8P2;CYP2D7AP;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6;cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2;cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 6;CPD6;P450-DB1;CYP2D;P450C2D
Cytochrome P450 2B6;cytochrome P450 family 2 subfamily D member 6;CYP2D6;CYP2DL1;CYP2D7P2;CYP2D7BP;CYP2D8P2;CYP2D7AP;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6;cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2;cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 6;CPD6;P450-DB1;CYP2D;P450C2D
Nicotinamide phosphoribosyltransferase;nicotinamide phosphoribosyltransferase pseudogene 1;NAMPTP1;PBEF2;NAMPTL;pre-B-cell colony enhancing factor 2;nicotinamide phosphoribosyltransferase-like;bA92J19.4
Nicotinamide phosphoribosyltransferase;nicotinamide phosphoribosyltransferase pseudogene 1;NAMPTP1;PBEF2;NAMPTL;pre-B-cell colony enhancing factor 2;nicotinamide phosphoribosyltransferase-like;bA92J19.4
Beta-secretase 1;beta-secretase 1;BACE1;BACE;beta-site APP-cleaving enzyme;beta-site APP-cleaving enzyme 1
CYTOCHROME P450 3A4;cytochrome P450 family 2 subfamily D member 6;CYP2D6;CYP2DL1;CYP2D7P2;CYP2D7BP;CYP2D8P2;CYP2D7AP;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6;cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2;cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 6;CPD6;P450-DB1;CYP2D;P450C2D
CYTOCHROME P450 3A4;cytochrome P450 family 2 subfamily D member 6;CYP2D6;CYP2DL1;CYP2D7P2;CYP2D7BP;CYP2D8P2;CYP2D7AP;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6;cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2;cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2;cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2;cytochrome P450, family 2, subfamily D, polypeptide 6;CPD6;P450-DB1;CYP2D;P450C2D
Cytochrome P450 7A1;cytochrome c oxidase subunit 7A1;COX7A1;COX7A;cytochrome c oxidase subunit VIIa polypeptide 1 (muscle);COX7AH
Glutathione S-transferase A1;glutathione S-transferase alpha 1;GSTA1;glutathione S-transferase A1
NAD(P)H dehydrogenase [quinone] 1;NAD(P)H quinone dehydrogenase 1;NQO1;NMOR1;DIA4;diaphorase (NADH/NADPH) (cytochrome b-5 reductase);NAD(P)H dehydrogenase, quinone 1;DHQU;QR1;DTD
Bile salt sulfotransferase;ATP binding cassette subfamily B member 11;ABCB11;BSEP;PFIC2;progressive familial intrahepatic cholestasis 2;bile salt export pump;ATP-binding cassette, sub-family B (MDR/TAP), member 11;ABC16;SPGP;PFIC-2;PGY4
ATP-binding cassette sub-family G member 5;ATP binding cassette subfamily G member 5;ABCG5;ATP-binding cassette, sub-family G (WHITE), member 5;STSL
ATP-binding cassette sub-family G member 8;ATP binding cassette subfamily G member 8;ABCG8;ATP-binding cassette, sub-family G (WHITE), member 8 (sterolin 2);ATP-binding cassette, sub-family G (WHITE), member 8;GBD4
ATP-binding cassette sub-family G member 5;ATP binding cassette subfamily G member 5;ABCG5;ATP-binding cassette, sub-family G (WHITE), member 5;STSL
ATP-binding cassette sub-family G member 8;ATP binding cassette subfamily G member 8;ABCG8;ATP-binding cassette, sub-family G (WHITE), member 8 (sterolin 2);ATP-binding cassette, sub-family G (WHITE), member 8;GBD4
ATP-binding cassette sub-family G member 5;ATP binding cassette subfamily G member 5;ABCG5;ATP-binding cassette, sub-family G (WHITE), member 5;STSL
ATP-binding cassette sub-family G member 8;ATP binding cassette subfamily G member 8;ABCG8;ATP-binding cassette, sub-family G (WHITE), member 8 (sterolin 2);ATP-binding cassette, sub-family G (WHITE), member 8;GBD4
ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 10 MITOCHONDRIAL;ATP binding cassette subfamily B member 10;ABCB10;ATP-binding cassette, sub-family B (MDR/TAP), member 10;EST20237;M-ABC2;MTABC2
Gastrotropin;fatty acid binding protein 6;FABP6;fatty acid binding protein 6, ileal;I-15P;ILLBP;I-BAP;ILBP3;I-BABP;ILBP;I-BALB
Bile acid receptor;G protein-coupled bile acid receptor 1;GPBAR1;BG37;GPCR;TGR5;M-BAR;GPCR19;GPR131;MGC40597
Nuclear receptor coactivator 1;RNA, U1 small nuclear 4;RNU1-4;RNU1E2;RNU1G2;RNU1D2;RNU1F1;RNU1G1;RNA, U1E2 small nuclear;RNA, U1G2 small nuclear;RNA, U1D2 small nuclear;RNA, U1F1 small nuclear;RNA, U1G1 small nuclear;HSD6;U1E2;HSD2;U1D2;HSD5;U1B2;U1F;HSD7
ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 10;ATP binding cassette subfamily B member 10;ABCB10;ATP-binding cassette, sub-family B (MDR/TAP), member 10;EST20237;M-ABC2;MTABC2
ATP-binding cassette sub-family B member 6, mitochondrial;ATP binding cassette subfamily B member 6 (Langereis blood group);ABCB6;ATP-binding cassette, sub-family B (MDR/TAP), member 6;ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group);EST45597;umat;MTABC3
MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1;ATP binding cassette subfamily C member 1;ABCC1;MRP;MRP1;multidrug resistance associated protein 1;ATP-binding cassette, sub-family C (CFTR/MRP), member 1;GS-X
Activating signal cointegrator 1 complex subunit 2;activating signal cointegrator 1 complex subunit 2;ASCC2;ASC1p100;FLJ21588;DKFZp586O0223
HLA class I histocompatibility antigen, B-44 alpha chain;major histocompatibility complex, class I, G;HLA-G;HLA-G histocompatibility antigen, class I, G
Beta-2-microglobulin;beta-2-microglobulin;B2M
EEYLQAFTY, self peptide from the ATP binding cassette protein ABCD3;ATP binding cassette subfamily D member 3;ABCD3;PXMP1;ATP-binding cassette, sub-family D (ALD), member 3;PMP70;ZWS2
ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4;collagen type II alpha 1 chain;COL2A1;SEDC;AOM;collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital);arthroophthalmopathy, progressive (Stickler syndrome);collagen, type II, alpha 1;collagen type II alpha 1;STL1
ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4;collagen type II alpha 1 chain;COL2A1;SEDC;AOM;collagen, type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital);arthroophthalmopathy, progressive (Stickler syndrome);collagen, type II, alpha 1;collagen type II alpha 1;STL1
COLLAGEN DERIVED PEPTIDE PCII-CIT1;C-X-C motif chemokine ligand 8;CXCL8;IL8;interleukin 8;chemokine (C-X-C motif) ligand 8;SCYB8;LUCT;LECT;MDNCF;TSG-1;IL-8;NAP-1;3-10C;MONAP;AMCF-I;LYNAP;NAF;b-ENAP;GCP-1;K60;GCP1;NAP1
